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Bullous pemphigoid is a blistering skin disease asso-
ciated with autoantibodies against the BP180 antigen, 
a trans1nen1brane con1ponent of the hen"Iidestnosotne. 
Anti-BP180 antibodies have been demonstrated to be 
pathogenic in a passive transfer n1ouse Inodel. One 
extracellular site on human BP180 (MCW-1) was 
previously shown to be recognized by 50-60% of 
bullous pemphigoid sera. To facilitate the identification 
of additional autoantibody-reactive epitopes, recOin-
binant forms of the BP180 ectodom.ain were generated 
using both bacterial and tnan1n1alian expression systen1s. 
One recon1binant protein, sec180e, that was expressed 
in COS-1 cells and that contained the entire BP180 
ectodornain, provided us with a tool to detect con-
formational epitopes. Bullous pemphigoid sera immuno-
adsorbed against the major noncollagenous NC16A 
domain no longer reacted with sec180e, indicating that 
autoantibody reactivity to the BP180 ectodomain is 
B ullous pemphigo id (BP) is a subepidermal autoimmune bli sterin g disease of the e.lderly characterized by ci.rculating and tissue-bound autoant ibod.ies that are deposited in a lin ea r f.1s hio n at the basement membr:me zone (BM Z) of the skin (reviewed by Z illikens et a/, "1996). T he anti -
BM Z autoantibodies are directed against two hemidesmosomal proteins, 
designated B P230 (B PA G l) and BPI80 (BPAG2) (S tanley eta/, 198 1, 
1988; Labib et a/, 1986; Diaz et nl, 1990; Liu et a/, 1994) . T he BPlSO 
antigen is a transmembrane glycoprotei n with a carbo~)'-termina l 
ectodomain containin g 15 collagenous and 16 no ncollagenous (N C) 
do mains (D iaz ct a/, l 990; Giudice et a/, 1991 , 1992; H opkinson cf a/, 
1992; Li et a/, 1993). T he NC l domain is located at the C term inus 
and NC16A is located adjacent to the transmembrane domain (Giudi ce 
et a/, 1992) . 
T he pathogenj c relevance of anti-BP1 SO antibodies has recentl y 
been established using an anim al model (Liu ct a/, 1993; Giudi ce 
ct a/, 1 995). Rabbit antibodies produ ced aga inst the murin e BPI SO 
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restricted to the NC16A region. Immunoblot analysis of 
bullous pemphigoid sera immunoadsorbed with a series 
of recombinant NC16A peptides revealed the presence 
of three novel autoantigenic sites that, along with the 
MCW-1 epitope, are clustered within the N-terminal 45 
amino acid stretch ofNC16A. All15 bullous pemphigoid 
sera tested reacted with a recombinant protein containing 
this BP180 segment. No disease-associated epitopes were 
detectable within the remaining 28 amino acids of 
NC16A. Thus, bullous petnphigoid patient autoantibod-
ies react with a set of epitopes on the BP180 ectodomain 
that are highly clustered. This autoantibody-reactive 
region on human BP180 shows overlap with the corres-
ponding murine BP180 site that is targeted by antibodies 
that are pathogenic in the mouse model of bullous 
pemphigoid. These findings suggest new directions for 
the development of diagnostic and therapeutic tools for 
this disease. Key words: autoimmunity I autoantigen I ltemides-
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eccodomain were shown to be pathogenic when passively transferred 
into neonatal mice. T his model reproduced the immu nopathologic 
features ofB P. R eactivity of th e pathogeni cally relevant antibodies has 
been mapped to a well-defined site w ithin the membrane-pro~imal 
no ncollagenous domain of murine BP1SO (homologous to the human 
NC16A do main (Liu el a/, 1995)]. 
A previo us immuno mapping swdy demonstrated that 60% of BP 
sera reacted with a 14 am ino acid stretch of the N C16A domai n of 
human BP180, designated MC W- 1 (Gi udjce et a/, 1993, 1994) . An 
enzyme-linked im munosorbent assay using a bacteria l fu sion protein 
con taining the MC W-1 site detected anti-BP1SO autoantibodies in 33 
of 62 (53%) BP sera. In addition to BP, an immune response against 
.13P1SO has also been fou nd in herpes ges tatio nis (G iudice et a/, 1993 , 
1994) and cicatri cial pemphigoid (Balding et a/ , 1 996) . Autoantibody 
reactivity to the BP1 80 N C 16A domain has been detec ted in all three 
of these subepithelial bullous diseases, and cica tricial pemphi goid sera 
additi onall y contain major immunoreactivity to the C-terminal regio n 
o fBP1 SO. 
Based o n previous studi es that indica ted that M C W-l is not th e 
sole anti genic site on BP"ISO recognized by BP sera (G iudice ct nl, 
1993), we have now rigorously probed the BPJ 80 ectodo main for 
additional autoanribody-reacti ve sites using several recombinant tools. 
One recombinant protein , sec180e, that was expressed in mammalian 
ce Lls, provided us with a tool to detect confo rmatio nal epitopes on the 
BPl80 ectodomai n. BP sera were depleted of specific populations of 
autoantibodies using BP1SO bac terial fusio n proteins, and th en assayed 
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Figure 1. Schematic diagratn of recombinant forn1s of the hmnan 
BP180 protein. T he transmembrant: region of BP'I80 is labeled "TM ," th e 
cytoplasmi c do main is shown to th e left and the C-tcrmina l ectodomoin , 
consisting o f 15 interrupted coll agen domai ns (slwrlerl boxes), is sho wn to the 
ti ght. Each of the fu sion proteins contains an N-termina l CST moiety. - --- -, 
deleted stretches. Amino acid res idue 11Lll1lbers are shown above the boxes. T he 
N C 16A do main has been subdi vided into fi ve regions, each of approximately 
15 amino acids in length. CST fusion protein 4575 represents a 49 amino acid 
stretch of th e Dl'1 80 C-terminal region. 
fo r reacti vity w ith secl SOe o r subf:i-agm ents of th e BP180 extracell ular 
d o main . Autoantibo d y reactivi.ty to .BP1 80 was found to b e almost 
entirely restt~ ctcd to th e N C 16A d o m ain . Three previo usly unc h arac-
te ri zed BP-re;~cti ve sites were identifi ed , all of whic h , alo n g with th e 
MCW-1 e pito pe, were sh o wn to be clustered w ithin the N -tenninal 
45 amino acid stre tch of N C l 6 A. 
MATErt.IALS AN D M ETHODS 
Human and rabbit sera Sera fi·om 'IS BP pati ents we re used in thi s stud y. 
By direct immunoAu oresc;ence (I F) of peril esional skin , all pati ents showed a 
line:n· staining ofC3 and /or lgG at th e DM Z . By indirect IF on sa lt-split skin , 
13 pati ents had circulating autoantibodi es that bo und to th e epiderma l side of 
the spli c. In the two cases that we re negati ve by indirect LF, direct IF analysis 
of peril esional skin biopsies trea ted w ith 1 M NaCI showed lgG deposits o n 
the epidermal side of th ~ dermal-epidermal split, confimt..ing th e di agnosis of 
BP. Seven of the 1 S 13P se rum sa mples in this study conta in ed antibodi es to 
BP230, as determined by immunoblotting with an epidermal extract. T hree 
rabbi t sera were used in this study. R 594 was raised aga inst a gluta thio ne-S-
transferase (GST) fusion protein containing 42 amino acids of the N C 16A 
domain (GST- N C 16A2-4). Serum R.136 was obtained from a rabbi t immunized 
with a B P1 80 fusion prote in conta ining 49 amjno acids of BP1 80 loca ted nc:tr 
the C termjnus, and rabbit serum R 58 was genera ted by immuniza ti o n with 
recombinant CST (Beclane cf nl, 1997; Balding cf a/, '.1997) . 
Preparation of hun1an BP1.80 recombinant proteins T he entire ecto-
domain of human BP1 80 was expressed as a secreted recombin:111 t peptide 
(sec !SOc) in transientl y tra nsfected COS-1 ceUs as described in derail elsewhere 
(Baldin g er of, 1997) . .Bri eAy, t.he eDNA encodi ng the N-terminal signal 
sequence and propeptide of human desmoglein- 1 and containin g the Kozak 
consensus translati on initiation si te, was subcloned in ro th e pSVL vecto r 
(Phannacia, Piscataway, NJ). Th is construct, designated pSVdsg l - leader, was 
used as a negative controL T he pSVsec 180 construct was genera ted by inse rting 
the eDNA encoding the entire BP ISO ec todorn ain into pSVdsg 1- leadei· so that 
the BP1 80 read ing fra me was in register with that of the dcsmoglein- 1 
leader sequence . 
CST fusion pro teins containing va ri o us fi·agments o f the human DP 'I80 
ectodomain we re generated using the pGEX bacte ri al expression sys tem 
(Pharmacia). T he no menclature for lll OSt of these GST fusion pro teins is based 
on subdividing th e B P1 80 N C l 6A domain into fi ve similarly sized subregions-
NC16A 1 thro ugh N C'I6A5 - tha t correspond to amino ac id segm ents 490-
506, 507-520, 52 '1-534, 535-548, and 549-562, respecti ve ly (Fig 1). This 
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amin o acid nUJnbering system is based o n th e pre mi se that th e tr::msbtio n start 
codon is located at nucleo tide # 106- 108 of th e previously p ublished human 
BP1 80 sequence (12; Ge ni3ank access ion # M91669) . The generatio n o f 
GST- N C16A2, GST-N C I6A2-3, GST- N C 16A2-4, and GST- N C16A2-5 was 
described in an earli er report (G iudice cr a!, 1. 993), as was the generati on o f 
fusion protein 4575, w hich contains 49 amino acids of the C- terminal region 
of BI' 'ISO (Balding cl a/ , '1996) . Constructs encoding fusion proteins GST-
N C !6A1 , GST-N C 16A3, GST- N C 16A1 -3, and GST- N C 16A1 -5 were 
generated in a similar manner. The I3P 'I80 inserts were obta ined by po lymerase 
chain reac ti on amplifi cati on (Mu llis et nl, 1986; Giudice el nl, 1993), and the 
products were subcloned into the BamHI/EcoR I site of pGEX-2T (Pharmac ia). 
The integrity of aLl inserts was confirmed by sequence analysis. BPl80 fusion 
pro teins were expressed in Esc/wric/iio coli strain DHSa and purifi ed by 
glutathion e-a&~rose affinity chromatograph y, as described previo usly (S mith and 
Johnso n 1988; Giudice e/ of, 1 993). 
Transient transfections and metabolic labeling COS- '! cells (A meri can 
Type C ulture Coll ection, 11-.ockvill e, MD) we re tr:msiently transfected using 
the di etb ylamin.oethyl- dextran method (Em.ery ef a/, 1995). Ten micrograms 
[Jl asmid DNA in phosphate-buffered saline, pH 7.4, containing 70 11M 
dieth ylaminoe th yl-dex tran were added to each 1 00-mm plate of cells (50-70%> 
ce ll density) . After 1 h at 37°C, chlo roquin e (9 .2 mM in DMEM) was added 
and th e cells we re incubated for another 2.5 h . The cells were trea ted w ith 
'10'){, d imethylsul fox ide/ DMEM for 2.5 min at room temperatute, and then 
incubated in ti·esh medium at 37°C. For metabolic-bbding experiments, the 
cells we re placed in methioninc-ti·ee medium (G J.BCO BI<. L, Ga ithersbu rg. 
MD) supp lemented w ith '10% fetal bovine serum and 35S-mcthioninc (25 mC i 
per ml ; NEN , B oston, MA) during the li nal 24 h of culture. 
Immunofluorescence of transfected COS- 1 cells COS-·t cells plated in 
eight-well chamber slides (Nunc, Naperville, !L) were transfected with eith er 
pSVLsec180 or the contro l constm ct as o utlined above. Sixty ho urs after DNA 
additio n, the cells were ft xed in 100% methanol at -20°C. Patient and human 
control sera were dilu ted 1 :SO in TBS-Ca ++ (150 mM NaCI, 'I mM ca lcium , 
I 0 mM Tri s, pH 7.5) with 10% fe tal bovine serum . R abbit se ra 1<.'136 and 
11..594 were dilu ted I :500. The transf<:>ctcd cells were incubated with the primary 
antibody fo r 30 min , was hed w ith TBS-Ca++, and th en incubated for 30 min 
w ith FIT C -Iabeled anti- human or anti - rabbit lgG (Kirkegaa rd and Peny, 
Gaithe.rsbmg, MD). After a fi nal seri es of washes w ith T BS-Ca ++, the labd cd 
ce lls we re exa mined using a Nikon epiAuorescence mi croscope. 
Imn"lunoblotting and irnn"lun oprccipitatio n Protein extr~cts V·lere frac-
tionated by 15% SD S-PAGE and d ectrophoretica lly transferred to n.itroccllulose 
(Labib cl a/, 1986; Giudice ef nl, :1993). B lo ts we re blocked for 45 min in PTX 
bufle r (0 .0 '1 M phosphate, pH 7 .5 , 0 .2% T riton X-1 00, 0 .15 M NaC I, 'I mM 
EGTA, 4% BSA). Human sera 13P- AN and BP- R U we re diluted ·r :800 in 
PTX, and all o ther human sera we re diluted :1: I 00 in this buffer. r~abbit sera 
w<:>rc diluted I :500. After a 15-h incubation with the primaty antibody, the 
blo ts were was hed, blocked fo r J 5 min with PTX buffe r, and incubated with 
125 !- labeled S tllpli)'lor:ocws mu·eus protein A. Ali:er a final seri es o f washes, bound 
antibodies were visualized by autoradiography. 
Inu1tur10prec ipitati on analysis was perfo rmed on labeled conditioned medium 
of transfected COS-1 ce ll s. Samples we re centrifuged at I 00,000 X s fo r I h 
at 1.1 °C in the presence of ·r% sarcosyl to remove insoluble aggrega tes. 
Supe rnatan t £i·ac ti o ns were th en in c ubated at roon1 temper3turc w ith th e 
primary antibody di luted in PTX bufrer. Human and rabbit sera were diluted 
·t :40 and I: I 00, respectively. After 1 h , protein A-conjuga ted agarosc beads 
(S igma , St. Lo uis, M O) we re added and in cubated fo r an additional hour. After 
pellet.ing, the beads were washed fi ve times with DM EM containing 1% 
sarcosy l. Finally, 25 111 of 5 X SDS-PA GE sample buffer was added to th e pell et, 
the beads were bo il ed fo r 4 min , and 30 pi o f the supernatam was analyzed by 
SDS-PAGE and Hu orography using Entensify reagents (D upont, Bosto n. MA). 
Immunoa.dsorption procedures lnununoadso rptions were perfo rmed using 
a li quid phase pro toco l as described previo usly (Martins el nl, '!990) . T he se ra 
were diluted in PTX (for immunoblo tting and immunoprccipi ta ti on) or T BS-
Ca++ (for indirect IF) and in cubated overnight with recombinant CST or with 
one of the CST fusion prote ins containjng vari ous segments of the N C 16A 
do main . T he mi xtures we re then centrifuged at ·r 0,000 X .~ fo r IS min at 4°C. 
lrnmunoadsorp tions were ve ti fiecl to be complete by the absence ofinnnun oblot 
reactivity with the recombinant protein that had been used as the immuno-
adso rbent. Preadsorberl se ra were used for indirect IF s tudi ~s o f transfected 
COS-1 cells, immunoblot analyses , and immun oprecipit~ ti on studi es . 
RESU LTS 
lmmuno.reac ti vity of .BP sera w ith th e ex tracellu lar regio n of .BP1 80 
is restric ted to the N C 16 A domain : C O S-I cells were transfected w ith 
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Table I. Reactivity of BP sera with sec180, a recombinant 
form. of the human BP180 ectodomain , is abolished 
after imm.unodepletion of autoantibodies to 
NC16A" 
Sera 
R 136, prei mmune 
R1 36, immune 
1<.594, prei nunune 
R594, immune 
BP-AN / GST 
J3P-AN/ NC16A 1-5 
BP-BLIGST 
BP-llLINC16A 1- 5 
BP-HE/GST 
BP-HE/ NC16A I-5 
BP-j A/GST 
BP-j A/ NC16A1-5 
BP-MA/GST 
BP-MA/ NCI6A 1- 5 
BP-RU / GST 
BP-I~U/NC 16A 1-5 
NHS-DZ/GST 
NHS-GG/GST 
NHS-LD/ GST 
Indirect immunoflu o rescence lmmunopreci pitation 
pSVdsgl-leader pSVsec180e pSVdsg l-bder pSVsec iSOe 
+++ +++ 
+ + + + ++ 
++ + + + 
+ + 
+ ++ 
+ + + + + 
(+) 
+ ++ 
+ + ++ 
"COS- 'l cells were transrcc.: tcd with either th e control construct pSVdsg l- lcader or with 
pSVscc 180. Cells were subj ected to indirect IF :malys is using sera rrom two rabbits (R J36 
:md R5lJ4, prc.i mnnmc :md in1mun c), six bp pat icnrs, and three he~1lth y comrols. Paricms' 
sera were preadsorbed with either recombinant GST or GST-NC 16A 1-5 :IS indicated 
after the slash m;~ rk . Contro l sera were imtmmo:.dsorbcd solely agai nst GST. For 
im munoprccipitat io n :111alysis, pSVscc180 and control rransfcc tcd COS- I cells wen:: 
mct:lbolica lly labeled w ith 35S-mcth io nin c, :1 nd tht: pn::clcan:d conditio ned media wert: 
re:1crcd w ith the s;~m~.:: scr~1 as ror the it~dircct IF ;~ n :1 l ysis. 
eith er the contro l co nstruct, pSVdsgl-leader, o r pSVsec'l80e encoding 
the e ntire BP180 ec todomain. Cells were ana.lyzed by indirect IF using 
rabbit sera R594 and R136, a pane l of BP sera , and serum samples 
fro m heal thy contro ls. The rabbit se ra were used at a di.luti o n of ·1 :500 , 
and the human sera at 1:50. The results are sununari zed in Table I , 
and representative staining patterns are shown in Fig 2. By indirec t 
IF, no ne of the rabbit o r human sera showed reactivity w ith cells 
transfec ted w ith the control construct (Fig 2B) , and no specifi c labeling 
was observed in pSVsec l 80e-transfected COS-1 ce lls labeled w ith 
normal human sera o r preimmun e rabbi t sera. In contrast, rabbit 
antiserum R594, generated against GST-N C 16A2-4, and antiserum 
1<...136, directed against the C-term.inaJ regio n of BP180, exhibited an 
intense pun cta te staining pattern in ce lls transfected w ith 
pSVsec180e (Fig 2A). An indistinguishable staining pattern was 
o btained w he n th ese sec180e-transfected cells were labeled with B P 
se ra. As expected, preadsorption of BP sera w ith recombinant GST 
did not alter th.is reactivity pattern (Fig 2C,E). Significantly, preadsorp-
tion of BP sera w ith fu ll - length NC16A comp letely abo lished the ir 
indirect IF reactivity w ith pSVsec180e-transfected COS-1 cells 
(Fig 2D,FJ. 
T he results of the immuno precipitatio n analysis w ith sec180e are 
summarized in Table I , and representative reactivity patterns are shown 
in Fig 3 . N o specifi c bands were de tec ted afte r immunoprecipitatio n 
of the condition ed medium of co ntro l transfe cted cells using any of 
the human o r rabbit sera (Fig 3 , lanes 1, 3, 5, 7, and 9). Likewise, 
imnwnoprecipitation analysis of pSVseclSOe-transfected cell cul ture 
m edjum w ith preinunun e rabbit sera or no rmal hlllnan sera produced 
no specific bands (Fig 3 , lane ~10). In contrast, rabbit sera R 594 and 
R 136 and BP patients' se ra preadsorbed w ith recombinant GST 
im.munoprecipitated a '120-kDa rad iolabeled band from pSVsec180e-
transfected cells (Fig 3 , Innes 2 and 6). Preadsorption of BP sera w ith 
a fi.1 sio n protein co ntaining full-l ength N C 16A completely abo lished 
their reac tivity w ith this band in five of six cases (Fig 3 , laue 4) . After 
preadsorption with GST-NC16A 1-5, serum BP-JA retained a weak 
level of reactivity with the 120-kDa secl 80e peptide (Fig 3 , laue 8). 
By densitometric analysis, this residual reac ti vity to sec180 corresponded 
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Figure 2. BP sera depleted of imn1unoreactivity to NC16A no longer 
react with pSVsec180e transfcctants by indirect immunofluorescence . 
OS- I cells were transfectcd with the BP ISO cctoclomain expression construct. 
pSVsec l80e (A, C-F), or with the nq,;~tive control construct, p Vdsg l- leader 
(B). Indirect IF bbding with rabbit anti-B P ISO antiserum R59-l produced a 
punctate staining pattern in pSVscc 180e-tl"' '"fecred cells (A), bu t showed no 
specific reactivity in the control transfected cells (B). Indi rect IF- labeling pa tterns 
produced by patient sera UP-AN and BI' - R.U preadsorbcd with GST (C and 
E, respectively) were very sim ibr to th:u obt:-~ in ed w ith R .. 59-L Afu.:: r liquid-
phase preadsorption of sera 13P-AN and llP- R U with the GST-N 16A 1-5 
fusion protein (0 and F, respectively), indirect IF reactivity with the tr:msfected 
cells was co111plerdy abolished. T hese results are representative of staining 
patterns obtained with other UP se ra. as shown in Table I. Srnle b111; (A-D) 
25 pm, (E :111d F) 10 pm. 
to Jess than 5% o f th e level of immun o reac tivity exhibited by the 
GST-adsorbed BP-J A serum. 
lmlnunoadsorp tiOJl studies indicate that there ar e at l e~st three 
BP-reactive ep ito pes loca ted in the BP180 N C 16A domain : as the 
m;~ ority of BP autoantibody- reactive sites were shown to be loca ted 
w ithiJl the N C 16A domain ofBP180, we next attempted to determine 
the fine specific ities of BP 180 autoantibodies directed to th is region 
of the protein. O ur general approach was to preadsorb BP sera w ith 
bacterial fusio n proteins containing va ri o us trun cated forms of th e 
NC16A do main (see Fig 1) and to assay the preadsorbed sera for 
immunoblot reactivity w ith a lo nger sub f.i·agm ent of the N 16A 
domain. Representati ve results of this ana lys is are shown in Fig 4 , and 
a compilation of the results from the eig ht BP sera assayed is shown 
in Table II. To eliminate potenti :tl immuno reacti vity of patient and 
control sera w ith the GST m o iety of the fus io n proteins, all se ra were 
preadso rbed w ith bacteria l extracts con ta ining recombinant GST. AU 
immunoadsorptions w ere shown to be complete by imnnmoblor· 
ana lysis as described above. 
In the first set of experim ents, BP sera were preadsorbed with the 
fusiot1 protein GST-NC1 GA2-5 , and th en assayed for reactivity w ith 
full- length NC16A. Seven of the preadsorbcd BP sera reta in ed the ir 
reactivity with fuLl-length NC1.6A (Fig 4 , lewes 1-4), w hereas one 
serum sample (BP-BE) los t its reactiv ity with GST-NC 16 A ·1-5 afte r 
preadsorp tio n w ith GST- N C 16A2-5 (see Table II). These data 
indica te that most BP sera reacted w ith o ne o r more epitopes loca ted 
w ithin region 1 of the NC 16A domain. In a second series of 
immunoadsorptio ns, BP sera were preadsorbed w ith the GST-NC16A2 
fusion protein (corresponding to the M CW-·1 antigenic site) and 
subsequently tested for reactivi ty with GST-NC 16 A.2-3. All but o ne 
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Figure 3. Ability ofBP sera to immunoprccipita te sec180 is abolished by 
deple tio n of autoa ntibodies to the BP180 NC16A domain . Metabo li cally 
J~tdiolabe l ed cul w re supe rnatants fro rn COS- J ce ll s transfected with 
pSVsec I HO (/<~li eS 2, 4, 6, 8, and I (}) or the contro l construct (/<111<'S 1, 3, 5, 7, 
and 9) we re used in an immu noprecipimtion assay to detect reacti vity of 13P 
patiem and ontro l sera with the 13 P 180 ectodomain. Prior to 
immunoprec ipitotion , the 13P- AN and UP-J A sera (as indica ted at the top of 
the pa nels) were preadsorbed with either recombinant CST (/llii CS ·1, 2, 5, and 
6) or GST-NCHiA 1-5 (la 11es 3, 4, 7, and 8). The immunoprecipitates were 
analysed by SDS-I'AC E and Auorography. A 120- kDa rad iolabeled band 
corresponding to sec·tsO can be seen in the immu noprecipitates in la11 es 2 and 
6. Preadsorption with CST-NC 16A 1-5 completely abolished the anti-secl80 
reac ti vity exhibited by 13 P- AN (la 11c 4) and greatly reduced the reac ti vity of 
UP-JA with sec I HI) (compare la11 cs 6 and 8) . A normal hurnan serum (N I-I S- I) 
showed no spec ific reactivity .in the i111munoprcc ipit:ttion assay. as ex pected 
(/ 111ws 9 and I 0). T he migration positions of molecular weight 1narkers of 200, 
11 6, 97, and (,6 kDa arc shown at the right. 
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Figure 4. N C16A regions 1 and 2 arc identified as potciltial sites o fBP 
immunoreactivity by imtnunoadsorption analysis. Four 13P sera (as 
ind ica ted below each pa nel) were tested for inun unoblot reactivity with a 
13 1'1 ~0 NC I fiA fusion prote in (as indica ted by the nurn bers immediately 
above e;lch lane) after prcadsorption with an N I C,A fusion protein (ind icated 
in the top porti on of the box above each lane). Lanes indicated with "-" were 
labeled with se ra that had been prcadsorbed with rccombinam CST. Serulll 
UP- AN reacted with CST-NC 16A2-5 and CST- NC16A 1- 5 (la11cs 'I and 2) . 
AfttT preadsorption with GST-NC 16A2-5, UP- AN no longer reacted with 
.ST- NC 16A2-5 (/a11c 3). but continued to reac t strongly with CST-NC1 6A 1-
5 (/a11c 4). After complete adsorption of se rum B l'- 1< E with CST-
NC 16A2 (co111pare lanes 5 and 7), this serum continued to react with CST-
NC 16A2-3 (lanes 6 and 8), but at a sl ightly dimin ished level. Preadsorption of 
se ru111 13P- Il..U with CST- NC 16A2-3 (/aii<'S 9 and I I ) abolished reacti vity of 
thi s sennn with GST- NC 16A2- 4 (/a11cs 10 and 12) . In a silllilar fa shion, 
complete adso rption of serum 13 P- UL with CST-NC 16A2- 4 (/alii's 13 and 15) 
resu lted in a complete loss of reactivity with CST- NCI6A2-5 (/r11ws 14 and 
16). T he migration positions of molecular we ight markers of 97, 66, 45 , 3 1, 
21, and 14 kDa arc ind icated to the right of each blot. 
of these preadsorbed se ra continued to reac t with GST-NC16A2-
3 (Fi g 4 , lnues 5-8), suggesting that anothe r immuno reactive site is 
located w ithin regio n 3 of th e N C 16A donia in . T he fi nal two 
se ri es of imm w wadsorp tio n experim en ts f;t il ed to uncover major BP 
autoantibody- reactive epitopes w ithin regio ns 4 and 5 of the NC J 6A 
domain. Preadsorption of B P sera w ith N C I6A2-3 resul ted in a 
com plete loss of reac tivity w ith GST-NC16A2-4 (Fig 4 , lnues 9- 12). 
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Preadso rption ofB P sera w ith NC i nA2- 4 led to the loss of reactivity 
w ith GST-N C 16A2-5 (Fig 4 , laues I 3-16). 
Four d istinc t antigenic sites located with in the N C I 6A do rmin are 
ta rge ted by BP se ra: as the immunoadsorptio n studi es suggested th at 
mul tip le au toa ntibody react ive sites w ere located in NC1 nA regio ns 
1-3, a se t of GST fusio n prote ins conta in ing all or portio ns o f this 
regio n of BP180 were gen erated in bacte ri a (see Fig 1) and utili zed 
in an imm un oblot analysis of BP and contro l Sl' ra. T he res ul ts of th is 
analys is are reported in Table III, and represt:n tative exa mples of the 
labelin g patte rns obta in ed are shown in Fig 5 . In tota l, 15 bp sera 
were <lssayed by immuno blotting for reactivity with the fo ll.owi n g six 
su bregions of the human B P lSO N C 16A dom ai n: regio n 1 (GST-
N C 16A 1; la11e 2), regio n 2 (GST-NCI6A2; la11 c .3), the junctio n of 
regio ns 2 and 3 (GST-NCI nA2 .5; fn11e 4), region 3 (GST-N 16A3; 
laue 5) , regions I thro ugh 3 (GST-NC16A 1-3; lnue 6), and the en tire 
N 16A dom ain (GST-NC 16A 1-5; ln~~e 7). Eq ual m ass an ro u nts of 
th t: various reco mbin am proteins we re used fo r this analys is. As 
d esc ribed above, all BP and contro l sera were p readsorbed with 
recom bi nant GST to el im inate reacti vity with the GST m oiety of the 
fusio n protei ns. GST was in clu ded in each imm u noblot assay (Jan e '/) 
to dem o nstrate that thi s adsorption was compl ete. 
As reported in Table III , all ·15 bp se ra reac ted both w ith full -
leng th NC16A (NC 16A 'I- 5) and wi th NC I6A 1- 3. T he in te nsities of 
the im mun oblot react ivities obtained w ith these two proteins was ve ry 
similar. Non e of the fusion p rote ins con ta ining o nl y a po rtio n of th e 
NC16A 1-3 region were recogn ized by aU of th e BP sera. Differe nt 
su bse ts of B P se ra reacted w ith NC16A regions 1, 2 , 3, and the 2 / 3 
j u nctio n . Notably, seven of the 15 bp se ra reac ted with on ly o ne of 
these fo ur NC16A regio ns: BP- DE and BP -TE reacted on ly w ith 
region 1, B P-C H and 13P-TU rea cted o nl y w ith region 2, and 13P-
13E, BP-M A, and BP-ST reac ted o nl y w ith N C 16A2 .5. Of the 15 B P 
se ra tested , ni n e reac ted w ith GST-NC 16A I , two different subse ts of 
e igh t se ra reacted w ith fu sio n proteins GST-NC.I6A2 and NC 16A2.5 , 
and o nly two sera reacted w ith N C 16A3. Incl uded in th is analysis was 
th e C-term ina l fusion protei n , 4575 (Fig 5 , lnuc 8), w hich has recently 
been shown to co nta in a C P-associated epirope (Bald in g c/ nl, 1 996) . 
O nly o ne of the 15 bp se ra, BP-J A, rea cted w ith 4575. 
D ISCUSS ION 
T he path ogen ic poten tia l of :m ti-B P1 80 antibod ies has been establi shed 
w ith th e rece nt deve lop m e nt of the experim en ta l m odel of .BP (Liu 
el nl, 1993, 1995; G iu d ice et a/, 1995). R.abbit polycloml an tibodies 
p repared against recom binan t forms of the m urine BP 180 ecrodo m ain , 
w hen passive ly transfe rred in to neonata l BAL.B /c m ice, were shown 
to in duce a subepi derm al bliste ring di sease that reproduces the key 
imm unopatho logic features o f B P. In te restingly, pathogen ica Ll y relevan t 
antibodies fi·o m mult iple rabb its have bee n shown to ex hibi t a highly 
restri c ted fin e speci fi city (Liu et nl, 1995) , rea cti ng with o n e site, 
mB P I , located w ithin the m aj o r nonco l.l ageno us stretch of th e muri n e 
BP180 extracellular do m ain (a regio n h o m o logous w ith the NC16A 
doma in of h u m an BP 180). In the present paper, w e now show that 
.BP autoan tibody reactivity to the human BP180 ectodom ain is alniost 
ent irely restri cted to the N C I6A dom ain. Fu rth er, we ide 11 tifi ed three 
novel B P autoantibody-reactive sites that, alo n g w ith the previously 
identifi ed M CW-1 site, are cl uste red within the N-terminal 45 amino 
acids of the NCl6A dom ain (regions ·1-3) . Afte r optimal seq uen ce 
ali gnm ent of the mu rin e and human B P1 80 ho m o logu es, it was fo un d 
that the m aj o r autoa ntibody- reactive regio n of hu man BP 180 has 
overl ap w ith the pathoge ni ca ll y re levan t site o n mmi ne B P1 80. 
Prev io us epitope mappin g studies o n au toan tigens re levan t in au to-
immune bullo us d iseases , in cl uding J3 P, pe mp hi gus fo li aceus, and 
epide rm o lysis bullosa acquisita, have relied o n immuno blottin g m e th ods 
using e ith er syn thetic peptides o r recombi nant proteins exp ressed in 
bacteri a. Al th o ugh these techniq ues were capable of u n covering linear 
ep itopes (R.ico et nl, '1990; Ta nab cl nl, 1990, '1994; All en c/ a/, I 993; 
Ga mmo n el a/, 1993 ; Lapi ere et nl, '1993; M tll e r el a/, 1993; J o nes ct a/, 
1995) , con fo rm atio n-dependent epitopes w e nt la rge ly unde tected. In 
the present study, we u tili zed a recombi nant protein e ncom pass ing the 
entire extracellula r do m ain of hum an BP180 exp ressed as a secreted 
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Table II. lmmunoadsorption analysis uncovers two novel BP-associated antigenic sites on the BP180 NC16A domain" 
ltcacrivi ry with 
NC I C>A 1- 5 afrt:r 
pr~adsoqnion with 
Lli' se ra NC 16A2-5 
lteacti vity with 
NC 16A2- 3 aft~r 
preadsorption with 
NC I6A2 
R.eactiviry with 
NC I6A2--l after 
prcadsorption with 
NC 16A2- 3 
R eacti vity with 
NC 16A2- 5 after 
preadsorption with 
NC I6A2-4 
Lli'-AL ++ 
LlP-A N +++ 
LW- l3E 
BP- 13L ++ 
13P- KE + 
13P-MA + 
13P-OS + + + 
UI ' - R.U + + 
+ 
+ 
+ + + 
++ 
+ 
+ 
II. d. 
+ + 
n.d. 
11 Bi' st:r:J (11 = 8) wc.Tt' subjL'Ctl'd to liquid ph:\$L' inHlll l! lO.Hisorprio n w irh lxt c t ~.· ri :JI ~e ll l ys~J tes com:1ining v:u ious t ru n c;~rcd St:gtn ents of rhe N C \6A do main . Prcadsorb~..·d sc r:.1 wt.:n' 
a-.s:-.ycd by inun un oblo t for th l.'i r rcac ri vi ry with :111 extended. atl-iniry- pu ri til'd ~; ub !i·, , gmc nt of the N C I GA do m.1it1. As a conrro l, sera \ Vc r (' preadsorbcd wi th cdl lys:-.rc "-·onrai ning 
n.·C0111binam GST. This did no t :dTCct tht.:ir rL·activiry with the v:tr ious fu sion prote ins. All inHilli!JO:Hisorpriom were vclif·icd to l)l' complc: rt.:: by th1..· :Jb s~..· n c ~..· of immunoblor rc;~ cti vity \Vith 
th e rcconJ bi n:Hl t protein th:H had LK'l' ll usL·d as tlt l.' inJ mun O:Idsorb ~..·ut. 
Table III. BP sera react with four distinct antigenic sites on NC16A by immunoblotting" 
131' sern NC I6A I NC I()A2 N 16A2.5 NC I6A3 NC IIoA I-3 NC I6AI- 5 4575 
13 1'- AL ++ + +++ + + + 
131'-AN + + + ++ + + + +++ + + + 
131'-DE + + + + ++ 
131'- l3L ++ +++ ++ + + + +++ 
UI'-C H ++ + + + + 
UP- DE ++ + + ++ 
131'-G U + + 
131'- HE + + + + +++ + + + 
131'-.J A + + ++ + + + + + + + + + + 
Lli'- KE +++ + + + + ++ + + 
131'- MA + + + ++ 
13P- l1...U + + + + + + +++ +++ 
131'-ST + ++ + + 
131'-TE ++ + + ++ 
13l'-TU ++ + + ++ 
Positive Ser:1 9/ IS S/ 15 8/ 15 2/ 15 15/ 15 15/ 15 1/ 15 
''BP sera (11 == 15) wcrl! dc plct~..: d of .111 ti- GST imn lull (H'l':lCtiviry .md rht.' II ;J ss:Jy~..·d fi> r immun oblot rc:H.:tivity with scvcr:ll CST fu sion pro teins contai ning diflCn.!nt porrions of rhc 
N C 16A don1ai n o f UP I HO. Fu.;; io n prorcin ..J.575 conr:1i no;; ;1 -l') .unino :u.:id stretch of th(' C-tcnnin:ll region of l3P IHO. 
BP-AN BP-KE BP-DE 
-
-
----
12345678 12345678 12345678 
Figure 5. BP sera react with four distinct sites on the BP180 NC16A 
domain. ltec01ubinnnt proteins were ti·nctionated by 15'!{, SDS- I'A , E. 
trn nsferred to ni trocel lulose, and lobd ed with three 131' sern , as indicated above 
each pa neL T he three inununoblots shown in this figure contain t:d the same 
loadings of recon1binant, 3fti ni ty purifi ed prote in s: CST (laue '/) , and fusion 
proteins NC IGAI, NC I(oA2, NC I!iA2.5, N 16AJ, NC I6A I-3 , NC I6A I- 5, 
3nd 4575 (laues 2- 8 , respectively) . T he !31' sera were preadsorbed with a 
bacterial cell lysate containing JTCO I!J binam CST to eli Jn inatc reactivity with 
the CST moiety of the fusion prote ins. The Jn igration positions of molecular 
weight markers of· 97, 66, 45, 31. 2 1, and 14 kDa arc indicated to the ri ght of 
each blot. T he patterns of immunoreactivity nrc rcprcsemativc of the p3tte rns 
revealed by other DP sera as shown in Table III. 
peptide in COS-1 cell s. A detai led biochemical and immuno logic 
characteriza tio n of sec180e (Balding el a/, '1997) revealed that this 
recombinan t p rotein e:-dsts in the fo rm o f :1 co llagen- like ho motrim eric 
complex, similar in structure to the endogeno usly expressed form of 
epithelial BI)JSO (Hirako e/ a/, "J991i) . T he ava ilability of sec J 80 
provided us w ith a too l to detect confo rmationa l epitopes o n th e 
BP ISO ec todo main . 
All BP sera reacted w ith sec 180e by indirect IF an:t!ysis of transfected 
C OS- ·1 ce lls and by immun o precipitation analysis. Significa ntly, fi ve 
of six BP sera preadsorbed aga inst a recombinan t peptide e ncompassin g 
th e 13Pl 80 N C 16A do main co mpletely lost their capacity to react with 
the fu ll - length 13P1 80 ectodomain . T he o ne remaining BP serum 
retained o nly a small fraction (les · than 5% as determj ned by de nsito-
m e tlic analys is of the immuno precipitated prod uct) of its immuno reac-
t.iviry with the BP1 80 ec todomain after preadsorptio n w ith N C I6A. 
Take n toge ther, th ese findings indi cate tlu t reactivity to the BP1 80 
extra cellular tail is large ly restri cted to the no n co llageno us NC 16A 
domai n. T his findin g is in agreement w ith the results of a recen t 
immun o blo tting study showing that 90% of l3P sera react w ith the 
BP"I80 NCI6A do main (M atsumura et a/, 1996) . ln add ition , based 
o n o ur results, the re maining portio n of the BP1 80 ectodomain does 
no t appear to contain nwj o r conformatio nal ep itopes . 
To aid in detenniniwr the fi ne specifi citi es of autoa ntibodi es bindjng 
to the BP180 NC16A do majn , a se ri es of nested recombinant NC 16A 
peptides was expressed as CST fu sio n pro teins in E. coli. lmmu noadsorp-
tio n and immunoblottin •~ ana lyses o f th ese peptides reveaJed th e 
presence o f three previo usly uncharacte ri zed 13P au toa ntibody- reactive 
sites. A bac terial fusion pro tein contain ing regio ns 2-5 o f NC 16A 
fai led to adsorb o ut reactivity o f BP se ra w ith full -length N C'J 6A (in 
seven of ejght cases), suggesting that a rn.ajor autoa n tibody-rea ctive site 
ex ists w ithin the N-termin al 17 amin o ac ids of th e N C 16A d01min 
(regio n l) . Wh en this poss ibjJity was tes ted directl y by immunoblo tting . 
nine of 15 bp sera (60%) showed reacti vity w ith GST-NC 16 A I . A 
high correlati o n was seen between the results of the immunoadsorpti o n 
and imm.unoblo t analyses . In (let, o nly o ne discrepancy was observed . 
Serum BP-MA reacted w ith N C J 6A 1- 5 afte r adsorptio n agaj nst 
N C I6A2-5; however, this serurn h1iled to react w ith N C 16A regio n 
1 by immuno blo ttin g . Two possibl e explanati o ns for this apparent 
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discrepancy are as fo llows: (i) serum BP-MA mi ght react with an 
ep itope that is present o n GST-NC16A2-5 and avai.labl e for antibody 
bindin g on an immuno blo t, but whi ch is masked wh en GST-NC16A2-
5 is dissolved in a phys io logic bufrer (under preadsorption conditions); 
(ii) serum BP- MA might react with an an tigeni c site that spans the 
junction betwee n NC16A regions 1 and 2. 
NC 16A region 3 was also identifi ed as a potential BP-reactive 
anti geni c site by immun oadsorp tio n procedures. Seven of seven bp 
sera compl etely depl eted of immuno reactivity with NC "I6A regio n 2 
retained reac tivity w ith the GST-NC16A2- 3 fu sion protein , suggesting 
that at leas t o ne other majo r antigeni c site is loca ted in N C J 6A regio n 
3 o r at the regio n 2/3 junctio n. We found that o nl y o ne of these 
seven BP sera recognized GST-NC16A3 by immunoblo tting . All six 
of the remaining BP sera reacted with a site that spans regions 2 and 
3 (NC 16A2 .5). Of a total of 15 bp sera that w ere tested, eight (53%) 
reac ted with NC16A2.5. Three of th ese positive BP sera do not 
recognize either N C l 6A regio n 2 o r N 16A regio n 3, indi ca ting th at 
a di sease-;1ssociated anti genic site does indeed span the junction be tween 
regio ns 2 and 3. 
The above results demo nstrate that the BP1 80 NC16A do main 
harbo rs BP-associated antigeni c sites located in re!,>ions 1, 2, and 3 and 
at th e junction of regio ns 2 and 3. T he respective percentages of BP 
sera that reac ted w ith these sites were 60%, 53%, 13%, and 53%. 
B eca use regio n 2 has previo usly been des ignated M W-1 , we now 
pro pose that th e three newly defin ed ;mtigenic sites (regio n 1, the 
2/3 juncti o n , and region 3) be designated M C W-0, M C W-2, and 
M C W-3 , respec ti ve ly. T he results of o th er immun oadsorptions indi-
ca ted that regio ns 4 and 5 of the N C 16A domain are devoid of maj o r 
autoantibody binding sites. Based on these re. ults, we genera ted anoth er 
BPI 80 fusio n pro tein that e nco mpasses N C 16A regio ns 1-3 . In contrast 
to the nin e o f J 5 bp sera (60%) that had previo usly been shown to 
react w ith ,ST-NC16A2 (M C W-1 ) (Giudice ct a/, 1993), we now 
show that all 15 of the randoml y selected BP sera in cluded in 
the curre nt study recognize the GST- N C I6A1-3 fu sion prote in by 
immunoblot analys is. In preliminary studies, an ELISA-based protocol 
using this fusio n protein was found to be specific and highl y sensiti ve 
fo r de tec ting circulatin g antibodies to B P1 80 in th e serum of pati ents 
w ith 13P. 1 Thus, th e 45 amino acid stre tch of BP"l 80 co rresponding to 
N C 16A regions 1-3 may w ell contain all of the major epitopes relevant 
to BP. 
ln previous studi es , we identifi ed an antigenic site in th e C-termin;d 
regio n of BP1 80 th at is recognized by a m;~ ority of cicatli cial 
pemphi goid se ra (Baldin g cl a/, "1996; Bedane et a/, 1997). Only o ne 
of the 15 bp sera includ ed in th e current study (B P-JA) reac ted w ith 
fu sio n protein 4575, w hich contains this C P-reactive site. Interest-
ingly, BP-JA was th e on ly serum that, after immun oadsorption agaimt 
GST- NC l6A, re tain ed a weak reac ti vity with sec180e by immuno-
precipitation. This underscores the point that, altho ugh the immuno-
reacti vity of BP sera is largely restri cted to the N C 16A domain, 
indiv idual se ra may contain som e reac tivity w ith othe r sites on th e 
BP 180 ec todomain , includin g its C-te rm inaJ portio n. 
T he tight clu ste1·ing of autoantibody-reactive epitopes documented 
in this study stands in contrast to the results of epito pe mapping studi es 
o n other bullo us disease-associated autoa ntige ns. For example, BP230 
and type Vll co llagen have been shown to con tai n multiple autoanti -
body-reac tive epitopes th at are distribu ted over relati vely large regions 
of th e targe t antigen (R.ico ci a/, 1990; Tanaka el a/, 1990, 1994; 
Ga mm o n e1 al, "1993; Lapiere el a/, 1993; Miller el a/, 1993; Peyron 
el a/, 1994; J ones el a/, 1995). Another interestin g fea ture of th e anti-
BP1 80 auto im mun e response in BP is the fmdin g that the major 
reactivity is directed to a regio n o f th e protein exhibiting a relative ly high 
degree of seq uence divergence between species . Human autoantibodies 
associated w ith many other diseases ha ve been shown to react w ith 
pro tein segments th at are phylogeneti ca Uy well co nserved, and some 
1Zillikens D, Mascaro JM , Rose PA , Liu Z, Ewing SM, Caux F, Hoffman RG , 
Diaz LA , G iudi c~ GJ. A highly sensitive enzyme-linked immunosorbent assay 
for the de tection of circuloting anti-B P"ISO wtoantibodi es in patients with 
bu ll ous pemphigoid . Submitted for pub li ca tion. 
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of these autoa ntibody-reactive sites have been shown to reside within 
functiona ll y important domains (reviewed by Tan , 1991 ). The func-
tional relevan ce of the N C 16A domain has not yet been elucidated, 
al though th ere is eviden ce that thi s regio n ofBP J 80 is ab le to associate 
w ith the a6 integrin subunit (Hopki nson et a/, 1995). 
In conclusio n , we have rigorou~ly probed the human BP180 
ec todomain and have demonstrated that the maj o r BP autoantibody-
reactive sites (th ree of whi ch were previo usly uncharacteri zed) are 
cluste red within a 45 amino acid stretch of the noncollagenous 
NC16A domain. To facilitate our search for antigenic sites, we used 
a recombinant protein , sec l SOe, that comprises th e entire BP180 
ectoclo main and has recently been show n to exis t in a coUagen-like 
homotrimeric conformatio n (Balqin g e1 a/, 1997), a stru cture similar 
to that ofB PJ SO endogeno usly expressed in mammalian epithelial ce lls 
(l-lirako cl a/, 1996). Combinin g Jiquicj phase immunoadsorption with 
immuno precipitation and immunoblotting techniques, we defined the 
major BP autoantibody-reactive region ot1 th e BP1 80 ectodomain . All 
BP sera tested showed reactivity w ith this regio n ofBP180. Interestingly, 
this majo r autoantibody-reac ti ve site overlaps with the ho m ologous 
site on murin e BP180 that is known to be rel evant in the pathogenesis 
of experimental BP. Wh ereas only 50-60% of BP sera reacted with 
recombinant form s of l3Pl 80 in our previous studi es , we now show 
that 100% of the randomly se lected BP sera react with a fusio n pro tein 
containin g the first 45 amino ac ids of NC l 6A . ft remains to be 
determined w heth er this site on the humanBPl SO ectodo main harbors 
th e initiating site for th e imn1.Line response in J3P. The findin gs o f the 
present study provide new insights into the path ogenesis of BP and 
sho uld aid in the development of novel diagnostic tools and therapeutic 
strategies for this di sease . 
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